Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00136084 · BASELINE

Baseline characteristics

Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia · Source last updated 2012-12-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      109
    2. group Id
      BG001
      value
      114
    3. group Id
      BG002
      value
      223
    units
    Participants
groups
  1. description
    High-dose Cytarabine (HDAC)
    id
    BG000
    title
    Arm 1: (HDAC)
  2. description
    Low-dose Cytarabine (LDAC)
    id
    BG001
    title
    Arm 2:(LDAC)
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          6.08
          value
          8.57
        2. group Id
          BG001
          spread
          6.32
          value
          8.48
        3. group Id
          BG002
          spread
          6.19
          value
          8.49
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          50
        2. group Id
          BG001
          value
          48
        3. group Id
          BG002
          value
          98
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          59
        2. group Id
          BG001
          value
          66
        3. group Id
          BG002
          value
          125
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      109
    2. group Id
      BG001
      value
      114
    3. group Id
      BG002
      value
      223
    units
    Participants
groups
  1. description
    High-dose Cytarabine (HDAC)
    id
    BG000
    title
    Arm 1: (HDAC)
  2. description
    Low-dose Cytarabine (LDAC)
    id
    BG001
    title
    Arm 2:(LDAC)
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          6.08
          value
          8.57
        2. group Id
          BG001
          spread
          6.32
          value
          8.48
        3. group Id
          BG002
          spread
          6.19
          value
          8.49
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          50
        2. group Id
          BG001
          value
          48
        3. group Id
          BG002
          value
          98
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          59
        2. group Id
          BG001
          value
          66
        3. group Id
          BG002
          value
          125
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice